Toronto Dominion Bank Neurocrine Biosciences Inc Transaction History

Toronto Dominion Bank

  • $49.5 Billion
  • Q1 2025

A detailed history of Toronto Dominion Bank transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Toronto Dominion Bank holds 15,208 shares of NBIX stock, worth $1.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,208
Previous 13,183 15.36%
Holding current value
$1.93 Million
Previous $1.8 Million 6.5%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$107.22 - $153.29 $217,120 - $310,412
2,025 Added 15.36%
15,208 $1.68 Million
Q4 2024

Feb 14, 2025
BUY
$111.62 - $139.44 $55,698 - $69,580
499 Added 3.93%
13,183 $1.8 Million
Q3 2024

Nov 14, 2024
BUY
$114.58 - $153.15 $358,749 - $479,512
3,131 Added 32.78%
12,684 $1.46 Million
Q2 2024

Aug 14, 2024
SELL
$130.86 - $143.19 $53,652 - $58,707
-410 Reduced 4.12%
9,553 $1.32 Million
Q1 2024

May 14, 2024
SELL
$130.4 - $143.74 $434,101 - $478,510
-3,329 Reduced 25.05%
9,963 $1.37 Million
Q4 2023

Feb 13, 2024
SELL
$106.07 - $132.76 $2.06 Million - $2.58 Million
-19,446 Reduced 59.4%
13,292 $1.75 Million
Q3 2023

Feb 14, 2024
SELL
$94.02 - $117.1 $450,731 - $561,377
-4,794 Reduced 12.77%
32,738 $3.68 Million
Q3 2023

Nov 14, 2023
SELL
$94.02 - $117.1 $450,731 - $561,377
-4,794 Reduced 12.77%
32,738 $3.68 Million
Q2 2023

Feb 14, 2024
BUY
$89.53 - $104.87 $2.17 Million - $2.54 Million
24,240 Added 182.37%
37,532 $3.54 Million
Q2 2023

Aug 10, 2023
BUY
$89.53 - $104.87 $896,642 - $1.05 Million
10,015 Added 36.4%
37,532 $3.54 Million
Q1 2023

May 11, 2023
SELL
$94.11 - $123.02 $123,284 - $161,156
-1,310 Reduced 4.54%
27,517 $2.78 Million
Q4 2022

Feb 07, 2023
BUY
$106.72 - $127.06 $841,487 - $1 Million
7,885 Added 37.65%
28,827 $3.44 Million
Q3 2022

Nov 09, 2022
SELL
$92.03 - $107.81 $28,253 - $33,097
-307 Reduced 1.44%
20,942 $2.22 Million
Q2 2022

Aug 11, 2022
BUY
$75.79 - $100.07 $71,091 - $93,865
938 Added 4.62%
21,249 $2.07 Million
Q1 2022

May 09, 2022
SELL
$72.45 - $94.81 $2.42 Million - $3.16 Million
-33,350 Reduced 62.15%
20,311 $1.9 Million
Q4 2021

Feb 04, 2022
BUY
$79.65 - $106.22 $3.21 Million - $4.28 Million
40,310 Added 301.92%
53,661 $4.57 Million
Q3 2021

Nov 08, 2021
SELL
$86.18 - $99.03 $7,325 - $8,417
-85 Reduced 0.63%
13,351 $1.28 Million
Q2 2021

Aug 13, 2021
BUY
$89.43 - $102.27 $1.2 Million - $1.37 Million
13,436 New
13,436 $1.31 Million

Others Institutions Holding NBIX

# of Institutions
649
Shares Held
97.6M
Call Options Held
749K
Put Options Held
553K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Toronto Dominion Bank Portfolio

Follow Toronto Dominion Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

News

Stay updated on Toronto Dominion Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email